The cost-effectiveness of prenatal screening for spinal muscular atrophy

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ajog.2010.01.032 Byline: Sarah E. Little (a), Vanitha Janakiraman (a), Anjali Kaimal (a), Thomas Musci (b), Jeffrey Ecker (a), Aaron B. Caughey (c) Keywords: cost-effectiveness; decision analysis; prenatal screening; spinal muscular atrophy Abstract: We sought to investigate the cost-effectiveness of prenatal screening for spinal muscular atrophy (SMA). Author Affiliation: (a) Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA (b) San Francisco Perinatal Associates, San Francisco, CA (c) Decision and Economic Analyses in Reproduction and Women's Health Group and the Center for Clinical and Policy Perinatal Research, University of California, San Francisco, School of Medicine, San Francisco, CA Article History: Received 22 November 2009; Revised 8 January 2010; Accepted 14 January 2010 Article Note: (footnote) Dr Caughey is supported by the Robert Wood Johnson Foundation as Physician Faculty Scholar RWJF-61535., Drs Ecker and Caughey served as senior authors., Cite this article as: Little SE, Janakiraman V, Kaimal A, et al. The cost-effectiveness of prenatal screening for spinal muscular atrophy. Am J Obstet Gynecol 2010;202:253.e1-7. , Reprints not available from the authors., The racing flag logo above indicates that this article was rushed to press for the benefit of the scientific community.